Adaptimmune Therapeutics plchttps://pcaobus.org/form-ap-filings/35784/35784Adaptimmune Therapeutics plc357843/20/2019 1:15:10 PM20182b029aaf-056e-4329-8f35-d8a57206126b1118KPMG LLP600241Adaptimmune Therapeutics plc1621227ADAP0111800001Charles Henry William le Strange Meakin0111800001True
Adaptimmune Therapeutics plchttps://pcaobus.org/form-ap-filings/22042/22042Adaptimmune Therapeutics plc220424/9/2018 1:32:25 AM20175f38b481-8b1b-4319-9d77-d032c6c212191118KPMG LLP600241Adaptimmune Therapeutics plc1621227ADAP0111800001Charles Henry William le Strange Meakin0111800001True
Adaptimmune Therapeutics Plchttps://pcaobus.org/form-ap-filings/3405/3405Adaptimmune Therapeutics Plc34053/21/2017 7:07:39 AM20167be10da8-1f28-4d3e-9f43-c9d42dc1f0681118KPMG LLP600241Adaptimmune Therapeutics Plc1621227ADAP0111800001Charles Henry William le Strange Meakin0111800001True